Fit for Surgery. Multimodal Prehabilitation in Colorectal Cancer Patients

March 2, 2022 updated by: Zealand University Hospital

Fit for Surgery. Clinical Randomized Trial of Multimodal Prehabilitation Strategy in Patients With Colorectal Cancer.

Randomized clinical trial of multimodal prehabilitation in vulnerable patients with colon or rectal cancer prior to surgery.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Fit for surgery is a randomized clinical trial of multimodal prehabilitation prior to colon or rectal cancer surgery. Participants will either receive

The study is a part of the PREHAB study which is performed in collaboration with international centers.

The full protocol are published BMC Cancer. 2019 Jan 22;19(1):98. doi: 10.1186/s12885-018-5232-6.

Study Type

Interventional

Enrollment (Anticipated)

48

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Danmark
      • Køge, Danmark, Denmark, 4600
        • Recruiting
        • Zealand University Hospital
        • Contact:
      • Slagelse, Danmark, Denmark, 4200

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Undergoing elective colorectal cancer surgery
  • WHO performance status I and II
  • Signed consent

Exclusion Criteria:

  • Known metastatic disease
  • Unable to perform baseline test or basic training e.g. paralytic or completely immobilized patients, orthopedic impairments.
  • ASA 4 or 5 (American Society of Anesthesiologist Classification)
  • Neoadjuvant chemo- or radiation therapy
  • Renal failure III B or higher
  • Illiteracy or unable to write or understand Danish
  • Cognitive disabilities, which affects adherence e.g. severe dementia (MMSE score ≤17).
  • Withdrawal of consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Prehabilitation
Patients receive multi-modal prehabilitation with exercise three times weekly, protein supplements, vitamin supplements, dietitian consultation and medical optimization prior to surgery. A minimum of four weeks.
A minimum of four weeks of prehabilitation with exercise three times a week, protein and vitamin supplements, dietitian consultation and medical optimization prior to surgery.
NO_INTERVENTION: Standard of Care
Receives standard of care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Recovery 15
Time Frame: 3 days after surgery
Difference in postoperative recovery between baseline and within 3 days after surgery. The cumulative score ranges from 0-150, with a higher value indicating a better outcome
3 days after surgery
Changes in physical fitness prior to surgery
Time Frame: Baseline, prior to surgery and 30 days after surgery
Changes in VO2 max between baseline and prior to surgery
Baseline, prior to surgery and 30 days after surgery
Complications
Time Frame: 30 days after surgery
Complications measured by the comprehensive complication index. The score ranges from 0-100 with with a higher value indicating a worse outcome.
30 days after surgery
Changes in immunological function
Time Frame: Blood work taken at baseline, prior to surgery, three days after surgery and four weeks after surgery. Tumor from resectionspecimen
Changes in immunological function measured by nanostring in blood and tumor (in the invasive front)
Blood work taken at baseline, prior to surgery, three days after surgery and four weeks after surgery. Tumor from resectionspecimen

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disease specific quality of life - EORTC c30
Time Frame: the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
European Organisation for Research and Treatment of Cancer Questionaire c 30 (EORTC c30). The EORTC c30 contains 6 domains which will each be assessed for mean changes in their cumulative score. The domains are physical function, role function, emotional function, pain, fatigue and global health. A higher value indicating a worse outcome
the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Disease specfic quality of life - EORTC c29
Time Frame: the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
European Organisation for Research and Treatment of Cancer Questionaire c 29 (EORTC). The questionnaire contains 29 items, with a 4 point Likert scale for symptoms and 7 point Likert scale for quality of life and global health. For the 4 point Likert scale the higher the score the worse the outcome. For the 7 point likert scale higher values indicating a better outcome. Analysis will be performed for changes in individual symptoms and cumulative aggregation of scores will not be performed.
the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Overall quality of life - SF-36
Time Frame: the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Short Form 36 question (SF-36) health questionnaire. The questionnaire contains eight domains: physical functioning, pain, limitations due to physical health problems, limitations due to personal or emotional problems, emotional well-being, social functioning, fatigue, and general health perceptions. Scores for each domain range from 0 to 100 and the analysis will be performed as mean difference between baseline and the following time frame. A higher value indicating a better outcome.
the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Psychological health - Depression - PHQ-9
Time Frame: the day prior to surgery,30 days after surgery, 60 days after surgery and one year after surgery
Patient Health Questionnaire 9 (PHQ-9) Depression test. The PHQ-9 have a maximum of 27 points and a minimum of 0. The outcome is point change between baseline and following time frame. A higher value indicating a worse outcome
the day prior to surgery,30 days after surgery, 60 days after surgery and one year after surgery
Psychological health - General anxiety - GAD-7
Time Frame: the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
General Anxiety Disorder 7-item (GAD-7). The questionnaire have a maximum of 21 points and a minium of 0. The outcome is the point change between baselin and the following time frame. A higher value indicating a worse outcome
the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Physical function (6-MWT)
Time Frame: The day prior to surgery, 30 days after surgery, and 60 days after surgery
6-Minutes walk test. Measures how far the participant can walk in 6 minutes measured in meters
The day prior to surgery, 30 days after surgery, and 60 days after surgery
Physical function (STS)
Time Frame: The day prior to surgery, 30 days after surgery, and 60 days after surgery.
Sit-to-stand test. Test of how many times the patient can rise from a chair in 30 seconds.
The day prior to surgery, 30 days after surgery, and 60 days after surgery.
Physical function (Stair climb test)
Time Frame: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Stair climb test will be measured as the number of steps (17 mc in height) the paitent can rise in 30 secounds.
The day prior to surgery, 30 days after surgery, and 60 days after surgery
Physical function (Leg extension test)
Time Frame: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Leg extension test will be measured by fixed dynaometer in newtons three times on each leg and the maximum for each leg used for analysis.
The day prior to surgery, 30 days after surgery, and 60 days after surgery
Physical function (Hand grip strength)
Time Frame: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Hand grip strength measured by hand-held dynanometer in kilograms. Measured 3 times on each hand and will use the maximum obtained.
The day prior to surgery, 30 days after surgery, and 60 days after surgery
Nutritional status
Time Frame: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Increase/decrease in total body weight in percent.
The day prior to surgery, 30 days after surgery, and 60 days after surgery
Remission and cancer free survival
Time Frame: 5 years
Remission and cancer free survival
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 1, 2019

Primary Completion (ANTICIPATED)

May 1, 2022

Study Completion (ANTICIPATED)

August 1, 2022

Study Registration Dates

First Submitted

November 11, 2019

First Submitted That Met QC Criteria

November 14, 2019

First Posted (ACTUAL)

November 18, 2019

Study Record Updates

Last Update Posted (ACTUAL)

March 3, 2022

Last Update Submitted That Met QC Criteria

March 2, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

Clinical Trials on Prehabilitation

3
Subscribe